MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
about
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsBreast cancer molecular subtypes: from TNBC to QNBCSystemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesNanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter dataThe PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression.Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysisNew targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersmicroRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.Critical analysis of the potential for microRNA biomarkers in breast cancer management.MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cellsMicroRNAs as potential biomarkers in cancer: opportunities and challengesEpigenetic Regulation of miRNAs and Breast Cancer Stem Cells.Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.miR-195 is a key regulator of Raf1 in thyroid cancer.Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma.Circulating small non-coding RNA signature in head and neck squamous cell carcinomaInduction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells.MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor.microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.The role of microRNA in resistance to breast cancer therapy.Role of miR-155 in drug resistance of breast cancer.MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.Identification of new miRNA biomarkers associated with HER2-positive breast cancers.Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells.Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2.Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
P2860
Q26744831-FDEE4EEF-D392-4267-8F62-6C8A8583F910Q26775086-13FA08B1-7B06-4CCE-9A7D-C216F7A884D6Q26796590-3C82113E-9A81-4E9C-86BB-F26426F96D9FQ28076805-91311D32-D29B-4D0E-B14E-A2FB59701028Q28080469-4CD5AF69-09B6-4BDF-9FC6-26B597EB8BA6Q31118292-78CB0787-5780-41DE-B065-23C8F8A7405EQ33591420-D0716539-6A9E-4586-A117-07269BB24622Q33775942-841A05BA-D107-4923-8FB1-2A20E3507D2BQ33778306-60263339-674D-415C-BB97-15146A6DA217Q33838622-D12A1ADD-80CD-4CE4-B93A-3A1AAE8A994DQ34064171-305A6FD3-15DF-4192-A25E-B0C4C56A19FFQ34706060-AD2E5F02-B19E-48EB-94E6-CFC65C19CD3FQ34982847-C6051979-C93A-42FE-90B1-117F9DCD0B84Q35125641-51632FF4-6714-4699-AA7C-29E4FA54B673Q35137273-BBC64A79-44BC-42D0-85E2-3501F7D2AEDBQ35233115-39A2EFB1-2D75-4EFB-829F-C8015FA05623Q35271157-6644247A-6048-4164-A90E-2EF534112306Q35673753-BF28B2DB-2B9D-4368-A779-3E954A719431Q35808066-7E95DA7F-CCA3-45B8-9781-CE6D3001B12EQ35883006-D6801981-DD7D-48B4-A47B-2792EBEE4A03Q36208479-C888539D-7F72-4723-83CB-2401C5450BFDQ36224803-1CD1E721-B225-4F43-A632-16B63B035291Q36326374-5434B00B-C3B6-4AA3-AD8A-92D10A76FDBDQ36338901-B2C97A0C-C1DE-41E2-81C8-6F09A568A573Q36464350-FB988F46-429E-407B-B4F3-C690DF474D47Q36502321-20DC38E4-6251-4584-9A29-1A89D2610F7FQ36508613-70D15E54-9A9A-48C3-B145-2CC82A3F444CQ36544789-525DD968-144E-4DF0-A986-14EB603EE61FQ36639624-9BD5AF1E-77FA-4700-B4E7-D8B924F6E248Q36647044-30625FD1-7A3B-40C9-85CD-554A356B7B8FQ36891545-EF4F4BDF-3A2F-4F99-A8BE-D0ABC6524BE5Q37697914-93115ED1-2586-40FE-A107-2153FD8D6059Q38231981-5AEF610A-582C-4BA8-872E-17596B11FEF2Q38368383-890D87AB-FFA2-4DC2-998C-DEFA81A3F694Q38693624-E2C9E8F4-054B-4DDD-8E64-017B661FF866Q38824331-2DE86C17-3CBB-49DF-AD04-A39B6CD903C4Q40178092-6E5788FE-35AB-40A4-91D3-B3BF37BCEDC8Q40209804-0156046F-9BFF-49B1-966C-C3A5CC1565D7Q47099331-652E5C5B-2E24-4122-8FF8-D03DEBD01267Q47612265-0D3DA08C-E80F-4109-8725-F207ADECC416
P2860
MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNA profiling implies new ...... triple-negative breast cancer.
@ast
MicroRNA profiling implies new ...... triple-negative breast cancer.
@en
MicroRNA profiling implies new ...... triple-negative breast cancer.
@nl
type
label
MicroRNA profiling implies new ...... triple-negative breast cancer.
@ast
MicroRNA profiling implies new ...... triple-negative breast cancer.
@en
MicroRNA profiling implies new ...... triple-negative breast cancer.
@nl
prefLabel
MicroRNA profiling implies new ...... triple-negative breast cancer.
@ast
MicroRNA profiling implies new ...... triple-negative breast cancer.
@en
MicroRNA profiling implies new ...... triple-negative breast cancer.
@nl
P2093
P2860
P1433
P1476
MicroRNA profiling implies new ...... triple-negative breast cancer.
@en
P2093
Guangqi Chang
Mao Ouyang
Shenming Wang
Weiming Lv
Wenjian Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0096228
P407
P577
2014-05-02T00:00:00Z